Eli Lilly to seek Olumiant approval in adolescents with alopecianews2025-10-24T14:17:22+00:00October 24th, 2025|Endpoints News|
Remix reveals first signs of tumor shrinkage with small molecule mRNA degradernews2025-10-24T14:00:54+00:00October 24th, 2025|Endpoints News|
Merus makes push into colorectal cancer with early positive datanews2025-10-24T14:00:03+00:00October 24th, 2025|Endpoints News|
Zai Lab shares Phase 1 data for lung cancer drug that could spar with Amgen’s Imdelltranews2025-10-24T13:00:14+00:00October 24th, 2025|Endpoints News|
Novo Nordisk lines up corporate affairs exec, overshadowed by board dramanews2025-10-24T11:00:57+00:00October 24th, 2025|Endpoints News|
Sanofi’s Dupixent sales continue to deliver as ‘negative buzz’ impacts vaccine franchisenews2025-10-24T10:49:57+00:00October 24th, 2025|Endpoints News|
FDA brings GSK’s Blenrep back to the market in multiple myelomanews2025-10-23T20:27:08+00:00October 23rd, 2025|Endpoints News|
Inhibrx will head to FDA for bone cancer drug next year after strong datanews2025-10-23T20:05:22+00:00October 23rd, 2025|Endpoints News|
FDA provides new checklists to prevent drug submission delaysnews2025-10-23T17:10:01+00:00October 23rd, 2025|Endpoints News|
Health tech investors are getting pickynews2025-10-23T17:03:53+00:00October 23rd, 2025|Endpoints News|
